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Formulation and evaluation of topical herbal gel for the treatment 
of arthritis in animal model
Rajasekaran Aiyalu*, Arulkumaran Govindarjan, Arivukkarasu Ramasamy
KMCH College of Pharmacy, Coimbatore, Tamilnadu, India
The objective of the study is to formulate and evaluate a topical herbal gel containing Cardiospermum 
halicacabum and Vitex negundo leaf extracts for their anti-arthritic activity in rats. Twelve herbal gel 
formulations were prepared using 1.5% of gelling agents carbopol 934 (F1-F6) and carbopol 940 
(F6-F12) and they were evaluated for physical appearance, net content, viscosity, extrudability, pH, 
spreadability, in vitro diffusion profile and primary skin irritation tests. The stability study for the topical 
herbal gel formulation was done as per ICH guidelines and anti-arthritic activity was evaluated by 
Freund’s Complete Adjuvant (FCA) induced arthritis method. Assessment of body weight, paw volume, 
hematological and biochemical parameters, histopathological examination and In vitro determination of 
serum biomarkers were also carried out. Formulated gels were homogenous, stable and complied with 
the guidelines. Among the formulations, F4 showed better release (98.4 %) characteristics than other 
formulations. No erythema or edema was observed in the skin irritation test confirming the gel was non-
toxic and safe. Topical application of the herbal gel F4 containing carbopol 934 displayed significant (p 
< 0.001) anti-arthritic activity compared to diseased rats. Reduction in paw volume, no agglutination in 
C - reactive protein and rheumatic factor, reduction in TNFα level, regaining of normal hematological, 
and biochemical parameters, reduction in spleen and thymus weight and histopathological examination 
supported the anti-arthritic activity of the gel formulation.
Uniterms: Arthritis/treatment/herbal gel. Cardiospermum halicacabum/topical herbal gel. Vitex negundo/
topical herbal gel. Medicinal plants/arthritis.
INTRODUCTION
Arthritis is an auto immune disorder that affects about 
0.5‐1 % of the population worldwide. The drugs commonly 
prescribed for Rheumatoid Arthritis are steroidal, non‐
steroidal anti‐inflammatory, disease modifying anti-
rheumatic and immunosuppressant drugs that are known 
to produce various side effects including gastrointestinal 
disorders, immunodeficiency and humoral disturbances. 
The Siddha and Ayurvedic systems of treatment are being 
increasingly recognized as an alternate approach for the 
arthritic treatment. The two plants most commonly used 
in traditional practice for the treatment of arthritis are 
Cardiospermum halicacabum and Vitex negundo.
Cardiospermum halicacabum (CH) (Sapindaceae) 
has been used in Chinese medicine for a long time in the 
treatment of inflammation, rheumatism and in various 
diseases (Jeyadevi et al., 2013). The anti-inflammatory 
activity of ethanol extract of CH reported to inhibit 
LPS induced COX-2, TNF-α and iNOS expression in 
RAW264.7 cells (Sheeba, Asha, 2009). Experimental 
pharmacological studies have shown the analgesic and 
vasodepressant activities (Gopalakrishnan, Dhananjayan, 
Kameswaran, 1976), anti-pyretic activity against yeast-
induced pyrexia in rats (Asha, Pushpangadan, 1999), 
anti-malarial (Waako et al., 2005), anti-oxidant activity 
(Kumaran, Karunakaran, 2006), anti-ulcer activity against 
ethanol induced gastric ulcer in rats (Sheeba, Asha, 2006) 
and suppression of the production of TNF-α and nitric 
oxide in human peripheral blood mononuclear cells (Babu, 
Krishnakumari, 2006). A number of compounds have been 
isolated and identified in CH, viz. arachidic acid, apigenin, 
apigenin-7-O-glucuronide, chrysoeriol-7-O-glucuronide 
and luteolin-7-O-glucuronide (Subramanyam et al., 2007). 
Vitex negundo Linn. (Verbenaceae) (VN) known as 
Nirgundi in Hindi, grows gregariously in wastelands and is 
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also planted as a hedge‐plant containing several flavonoids 
such as casticin, orientin, isoorientin, luteolin, lutecin‐7‐ 
O‐glucoside, corymbosin, glycosidic iridoids, alkaloids 
and terpenoids (Nair, Mohenan, 1998). VN has been 
documented for potent anti-arthritic (Tamhankar, Saraf, 
1994), anti-inflammatory, anti-pyretic (Telang, Chatterjee, 
Varshneya, 1999), anti-convulsant (Gupta, Mazumder, 
Bhawal, 1999), hepatoprotective and bronchial relaxant 
(Nair, Mohenan, 1995). They are also used as tonics, 
vermifuge, lactagogue, emmenagogue, anti-bacterial, anti-
pyretic and anti-histaminic agents (Ghosh, 1984).
There is no report on preclinical studies of CH and 
VN on topical gel for its anti-arthritic activity and hence 
a topical herbal gel was developed using CH and VN 
and evaluated for anti-arthritic activity, to explore the 
scientific proof for the use of these plants in the treatment 
of arthritis. CH and VN was formulated in the form gel as 
the administration of gel is easy, causes localized effect, 
no pain or irritation during application, no first pass effect 
and no GIT degradation and can be delivered directly on 
to the affected area.
Though all parts of CH and VN are used as medicine, 
leaves are used majorly for treating arthritis in traditional 
medicine (Kumar et al., 2008) and hence topical gel 
formulation was designed using the leaf extracts of both 
the plants.
MATERIAL AND METHODS
Material
The mature fresh leaves of Vitex negundo and 
Cardiospermum halicacabum were collected from 
Palakkad, Kerala, and authenticated by GVS Murthy, 
Director of Botanical Survey of India, Coimbatore. 
Freund’s complete adjuvant (FCA), diclofenac sodium, 
triethanolamine, propylene glycol and disodium edetate 
were purchased from Sigma‐Aldrich USA. Carbopol 934 
and carbopol 940 were obtained from Loba Chemie Pvt. 
Ltd. Mumbai.
Preparation of extracts
The leaves of Vitex negundo and Cardiospermum 
halicacabum were processed to remove earthy matter 
and residual materials carefully from the leaves, then 
cleaned and shade dried. Coarse powdered leaves of 
Cardiospermum halicacabum was extracted in a Soxhlet 
extractor with methanol for 72 h. Coarse powdered leaves 
of Vitex negundo was extracted with methanol by cold 
maceration process for 7 days. Both the extracts were then 
filtered and concentrated under reduced pressure in IKA 
Rotary evaporator (Model No RN 10 digital V, ILMAC 
Germany) at 40 °C and stored at 4-8 oC for further use.
Animals
Wistar strains rats (12-week old healthy) weighing 
150-200 g of either sex in the animal house of KMCH 
college of Pharmacy, Coimbatore, Tamil Nadu, India 
were selected for anti-arthritic evaluation. Female albino 
mice weighing 20-30 g were used for acute toxicity 
study and albino rabbits (average weight 2.2 kg) were 
used for primary skin irritation test. They were housed 
under controlled conditions of temperature (23±2) oC, 
humidity (50±5) RH and 10-14 h light and dark cycles. The 
animals were housed individually in polypropylene cages 
containing sterile paddy husk bedding and free access to 
food and water ad libitum.
The experiments were designed and conducted in 
accordance with ethical norms approved by Committee for 
the Purpose of Control and Supervision on Experiments 
on Animals (CPSCEA) and Institutional Animal Ethical 
Committee (KMCRET/DRDO/01/2011, dt.16/07/2011).
Preparation of gel base
Carbopol 934 was dissolved slowly with stirring 
in 60 mL of demineralized water for 1 h to avoid 
agglomeration Then disodium edetate and triethanolamine 
were dissolved in 10 mL of demineralized water separately 
and stirred for 10 min. Mixed 4.83 mL of propylene glycol 
in 12 mL of demineralized water with stirring for 10 min. 
Disodium edetate and triethanolamine solution were added 
to carbopol solution and the pH was then adjusted to 7.4 
by stirring the solution for 10 min. Then propylene glycol 
solution was added with stirring for 10 min until a clear 
consistent gel base was obtained.
Preparation of gel formulation
Twelve topical gel formulation was prepared 
using CHME (methanol leaf extract of Cardiospermum 
halicacabum )and VNME (methanol leaf extract of Vitex 
negundo) as per drug formulation manual where F1 to F6 
formulations were made using the gel base of carbopol 934 
(1.5 %) and F7 to F12 formulations were made using the 
gel base of carbopol 940 (1.5 %). Details of formulation 
compositions are recorded in Table I.
The F4 formulation prepared using carbopol 934 
was evaluated for anti-arthritic activity as it exhibited 
better quality characteristics.
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Quality control of topical herbal gel formulation
Estimation of active constituents in gel formulation (net 
content)
Each formulation (1 g) was taken in a 50 mL 
volumetric flask and made up to volume with methanol and 
shaken well to dissolve the active constituents in methanol. 
The solution was filtered through Whatman filter paper 
and 0.1 mL of the filtrate was pipetted out and diluted to 
10 mL with methanol. The content of active constituents 
was estimated spectro photometrically by using standard 
curve plotted at 275 nm (λmax of active constituents in the 
extracts) (Nandgude et al., 2008).
Extrudability
A closed collapsible tube containing about 20 g of 
gel was pressed firmly at the crimped end and a clamp was 
applied to prevent any roll back. The cap was removed and 
the gel was extruded. The amount of the extruded gel was 
collected and weighed. The percentage of the extruded 
gel was calculated (Nappinai, Pakalapati, Arimilli, 2006).
pH measurement
pH measurement of the gel was carried out using 
a digital pH meter by dipping the glass electrode 
completely into the gel system to cover the electrode. The 
measurement was carried out in triplicate and the average 
of the three readings was recorded (Queiroz et al., 2009).
Appearance and Homogeneity
Physical appearance and homogeneity of the 
prepared gels were evaluated by visual perception.
Viscosity
Viscosity of gel was determined using Brookfield 
viscometer (S-62, model LVDV-E) at 25 oC with a spindle 
speed of the viscometer rotated at 12 rpm (Nayak et al., 
2005).
Spreadability
Two sets of glass slides of standard dimensions were 
taken. The herbal gel formulation was placed over one of 
the slides. The other slide was placed on the top of the gel, 
such that the gel was sandwiched between the two slides in 
an area occupied by a distance of 7.5 cm along the slides. 
Hundred g weight of gel was placed on the upper slides 
so that the gel was between the two slides was pressed 
uniformly to form a thin layer. The weight was removed and 
the excess of gel adhering to the slides was scrapped off. The 
two slides in position were fixed to a stand without slightest 
disturbance and in such a way that only upper slides to slip 
off freely by the force of weight tied on it. A 20 g weight 
was tied to the upper slide carefully. The time taken for the 
upper slide to travel the distance of 7.5 cm and separated 
away from the lower slide under the influence of the weight 
was noted. The experiment was repeated for three times and 
the mean time was taken for calculation. (Jain et al., 2007).
Spreadability was calculated by using the following 
formula:
S= m × l/t
where, S= spreadability, m-weight tied to upper slides 
(20 g), l- length of the glass slide (7.5 cm), t- time taken 
in sec.
TABLE I - Gel formulations with carbopol 934 and carbopol 940
Gel code
Cardiospermum 
halicacabum extract 
(g)
Vitex 
negundo 
extract (g)
Carbopol 
934 
(g)
Carbopol 
940 
(g)
Triethanol 
amine 
(g) 
Disodium 
EDTA 
(g)
Propylene 
Glycol 
(g)
D.M. water 
(100 g)
F1 0.5 0.5 1.5 --- 1.5 0.005 5 q.s
F2 1 1 1.5 ---- 1.5 0.005 5 q.s
F3 1.5 1.5 1.5 ---- 1.5 0.005 5 q.s
F4 2 2 1.5 ---- 1.5 0.005 5 q.s
F5 2.5 2.5 1.5 --- 1.5 0.005 5 q.s
F6 3 3 1.5 ---- 1.5 0.005 5 q.s
F7 0.5 0.5 --- 1.5 1.5 0.005 5 q.s
F8 1 1 --- 1.5 1.5 0.005 5 q.s
F9 1.5 1.5 ---- 1.5 1.5 0.005 5 q.s
F10 2 2 ---- 1.5 1.5 0.005 5 q.s
F11 2.5 2.5 ---- 1.5 1.5 0.005 5 q.s
F12 3 3 --- 1.5 1.5 0.005 5 q.s
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In vitro diffusion profile
In vitro permeation in rat skin
In vitro diffusion studies for all formulations were 
carried out using Franz diffusion cell. The diffusion cell 
apparatus was fabricated locally as open-ended cylindrical 
tube with 3.7994 cm2 area and 100 mm height having a 
diffusion area of 3.8 cm2. Phosphate buffer (pH 7.4) was 
used as receptor media. Rat abdominal skin was used as 
dialysis membrane. The skin was tied to the diffusion 
cell (donor cell) such that the stratum corneum side of 
the skin was in intimate contact with the release surface 
of the formulation in the donor cell. Isotonic phosphate 
buffer solution, pH 7.4 (100 mL) was added to a donor 
compartment prior to be mounted on the diffusion cell. A 
weighed quantity of formulation equivalent to 1 g of gel 
was taken on to the rat skin and was immersed slightly 
in 100 mL of receptor medium, which was continuously 
stirred. The entire system was maintained at 37±1 ºC. An 
aliquot of 5 mL was withdrawn at specific time intervals 
up to 8 h, and was estimated spectrophotometrically at 
275 nm. After each withdrawal, the diffusion medium was 
replaced with an equal volume of fresh diffusion medium. 
The cumulative percent release was calculated for each 
time (in h) interval.
Release kinetics
To find out the release pattern of active constituent 
from herbal gel, data obtained were fitted to different 
mathematical models (Martin, 1994). Zero order kinetics 
is a concentration independent kinetics and first order 
kinetics is the dependent kinetics, where drug release may 
follow swelling and erosion or simply diffusion. Data were 
validated using Higuchi’s model to ascertain the reaction.
Stability studies of topical herbal gel formulation
The main objective of the stability testing is to 
provide evidence on how the quality of the drug product 
varies with time under the influence of temperature and 
humidity. The stability study for the topical herbal gel 
formulation was done as per ICH guidelines in a stability 
chamber for a period of 6 months. The selected topical 
herbal gel formulation consisting of 2% of each CHME 
and VNME was loaded in a humidity chamber (Floor 
standing model, 3 units in one with individual humidity 
and temperature controller, 300 X 300 X 300 mm, 15-
60°C, Technico, India) at 25°C ± 2°C/60% RH ± 5% RH, 
32°C ± 2°C/60% RH ± 5% RH and 40°C ± 2°C/75% RH 
± 5% RH. Samples were withdrawn at an initial, first, 
second, third and sixth months and evaluated for change 
in color, odor, homogeneity, pH, viscosity, net content, 
microbial load and sterility test.
Anti-arthritic activity
Efficacy of the topical herbal gel formulation was 
studied by FCA induced arthritis model (Mizushima, 
Tsukada, Akimoto, 1972) in rats through topical 
application. The rats were divided into four groups, each 
consisting of six animals. Group 1 was applied topically 
with gel base considered as normal control. Arthritis was 
induced to group 2 to 4 by injecting a 0.1 mL (0.1% w/v) 
suspension of killed Mycobacterium tuberculosis bacteria 
(Genei, Bangalore) homogenized in liquid paraffin into 
the left hind foot in the subplantar region of rats. Group 
2 was considered as arthritic control. Groups 2 to 4 
administered with FCA were allowed to develop arthritis 
for 21 days. During the experimental period, body weight 
and the rat paw volume of control and treatment groups 
were measured on 4th, 8th, 14th and 21st day by using digital 
Vernier caliper (Mitetoyo digimatic caliper, Japan).
After the confirmation of arthritis development, 
diclofenac sodium gel (Voveran gel, purchased from 
community pharmacy shop) and the herbal gel formulation 
F4 were applied topically for 22 to 42 days to the left knee 
joint region of Group 3 (served as reference standard) and 
groups 4 respectively. 
During the treatment period, the body weight of the 
animals and the rat paw volume of control and treatments 
were measured on 25th, 29th, 35th and 42nd days by using 
digital Vernier caliper (Mitetoyo digimatic caliper, Japan). 
At the end of 42nd day the pain test score of the animals 
were recorded visually (Laird et al., 2001).
Hematological parameters
The overnight fasted animals were anaesthetized 
with ketamine (20 mg/kg, i.p) followed by withdrawal of 
blood samples from retro-orbital sinus and the collected 
blood samples were centrifuged at 10000 rpm for 10 
min and evaluated for hematological parameters viz. 
Hematological parameters like red blood cell (RBC) count, 
white blood cell (WBC) count, hemoglobin (Hb) value, 
erythrocyte sedimentation rate (ESR) were evaluated using 
routine laboratory methods (Patil, Patil, Jadhav, 2009). 
The separated serum was analyzed for urea, uric acid 
and serum biomarkers viz. CRP, RF (Omega diagnostics 
Limited, Scotland, UK), TNFα (ELISA Kit, Gen-Probe, 
France), IL-1ß and IL6 (ELISA Kit, R&D systems, USA).
Biochemical estimations
A portion of the blood samples were centrifuged 
at 10000 rpm for 10 min and the separated serum was 
Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model 497
analyzed for biochemical parameters viz. Cholesterol, 
triglycerides, VLDL levels SGOT, SGPT, ALP, total 
bilirubin, total protein, albumin, globulin, urea, uric acid 
and creatinine. Biochemical investigations were carried 
out in a autoanalyser (Photometer 5010 V5+, Robert Riely, 
Berlin) using Piramal healthcare limited reagent kit.
Histopathological investigations
The animals were sacrificed by cervical dislocation 
and the organs thymus, spleen and bone joints of ankle 
joint were isolated and weighed after separating the 
superficial fat. The isolated ankle joint was immersed 
for 9 days in Cal-Ex Decalcifying solution CSS10-1D 
(Fischer Scientific, India). The ankle joint was then 
embedded in paraffin, sectioned serially (6 µ) using 
microtome, mounted on a microscope slides and stained 
with Harris hemotoxylin and Eosin (Murphy et al., 2003). 
Histopathological changes in the joints rats were examined 
under microscope and digital images were acquired.
Statistical analysis
All the data expressed as mean ± SEM were 
evaluated by one-way analysis of variance (ANOVA), 
followed by Dunnett’s test for multiple comparisons using 
prism Graphpad version 5.0 and values of P<0.05 were 
considered as statistically significant.
Skin irritation study
Three young adult rabbits were housed in metal 
cages fitted with perforated floors. Water and standard 
rabbit feed were given ad libitum. The room temperature 
was maintained at 22 ± 3 °C with 30 - 70 % relative 
humidity. The light conditions were controlled to give 
12 h artificial light (8 am - 8 pm) each day. Twenty four 
h before the test (dose application), hair on the back 
and flanks of each rabbit were shaved cleanly, exposing 
approximately 6 cm2 area of skin. The final gel formulation 
was evenly applied to 4 cm2 area of the closely clipped 
skin of each rabbit. Skin reaction at the site of application 
was subjectively assessed and scored once daily at 1, 24, 
48, 72 h, 7 and 10 days (post test observation period) 
accordingly.
RESULTS AND DISCUSSION
In general, gel formulation is more preferred, among 
the other topical semisolid preparations, since it has long 
residence time on the skin, high viscosity, moisturizing 
effect on flaky skin due to their occlusive properties, more 
bio adhesiveness, less irritation, independent of water 
solubility of active ingredient, ease of application and 
better release characters (Loganathan et al., 2001). Many 
studies have indicated that flavonoids such as luteolin 
and apigenin in herbs possess anti-inflammatory and anti-
arthritic activity. Further, these polyphenolic flavonoids, 
apigenin and luteolin reported that they can penetrate the 
human skin (Giinter et al., 2008) and hence a topical herbal 
gel formulation was designed containing these flavonoids 
for the treatment of arthritis.
Formulation and evaluation of topical herbal gel
Twelve different gel formulations (F1 to F12) were 
prepared using different concentrations (0.5, 1, 1.5, 2, 
2.5 and 3% w/w) of methanol extract of Cardiospermum 
halicacabum and Vitex negundo, with 1.5 % concentration 
of Carbopol 934 or Carbopol 940 polymer respectively. 
Carbopol 934 and carbopol 940 were used as gelling agent 
in the formulation as they are biodegradable, bioadhesive, 
biocompatible, irritation free and not absorbed into body. 
Among the two polymers used, carbopol 934 was 
reported to have more gelling property than carbopol 940 
(Blonco-Flonte et al., 1996), which is in correlation with 
our study. Carbopol 934 polymer proved to be a promising 
carrier for controlled release of active phytoconstiuents in 
the gel formulation.
The percentage of polymer was optimized after 
preparing the gel with various concentrations from 0.5 to 
2.5%, where the 1.5 % of carbopol (934 or 940) containing 
gels was found to be compatible with the requirements of 
gel formulations. 
From the quality control test, it was apparent that 
the gel formulations prepared with Carbopol 934 (F1 to 
F6) as a gelling agent were found to be superior to the 
gel formulations prepared with Carbopol 940 (F7 to F12) 
except only spreadability parameters where Carbopol 
940 was found to be good. Hence the in vitro diffusion 
studies were carried out only for the six herbal topical gel 
preparations F1 to F6, formulated using carbopol 934 and 
the in vitro release and stability studies were carried out 
for the best herbal gel formulation F4.
Dimethylsulfoxide and propylene glycol are 
reported to be the two best permeation enhancers 
(Panigrahi et al., 2006). Since DMSO reported to 
causes skin erosion we have used propylene glycol 
as permeation enhancer in the preparation of the gel 
formulation (Walker, Smith, 1996). Disodium edetate and 
triethanolamine were used in the formulation in order to 
adjust the pH of the formulation.
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Quality control test for formulated topical herbal gel 
Twelve gel formulations F1 to F12 prepared 
using carbopol polymers were evaluated for physical 
appearance, pH, viscosity, spreadability, net content, 
extrudability and in vitro diffusion profile. Results 
of the study were in acceptable limits of the ICH 
guidelines and the details of the same are recorded in 
Table II.
Prepared gels were found to be homogeneous and 
in good appearance and consistency. The pH values of 
all the formulations were in the close range of neutral pH 
(7.42-7.88) and hence it caused no skin irritation, which 
is also supported by skin irritation study. 
Polymers were included in the designed topical 
formulations in order to provide a prompt release of 
drug and to achieve as well as to maintain the drug 
concentration within the therapeutically effective range. 
As the concentration of the polymer was fixed as 1.5% 
in all the gel formulations no variation in viscosity was 
observed. Further the value between 0.38 and 0.39 poise 
was reported to be an ideal viscosity value for topical gel 
formulation developed using carbopol polymers (Kim et 
al., 2003).
Values of the spreadability indicated that the 
gel formulations are easily spreadable. Among the gel 
formulations F1 to F6, more than 90% of the contents were 
extrudable indicating they have excellent extrudability 
except F1 and F3 as 80% of the contents were extrudable 
(>90% extrudability: excellent, >80% extrudability: good, 
>70% extrudability: fair).
In vitro diffusion profile and release kinetics
In vitro diffusion profile of F1 to F6 formulations are 
recorded in Figure 1. Since the pH of membrane used was 
in the range of 5 to 7.8, phosphate buffer saline pH 7.4 was 
used for the in vitro release studies of the gel formulations. 
The in vitro release profiles of all the six formulations 
made using carbopol 934 elicited almost 100 % release 
from the formulation within 5 h. 
The in vitro release characteristics of the prepared 
topical herbal gel formulations were quite encouraging and 
in agreement with marketed diclofenac gel. 
Among the formulations, F4 showed better release 
(98.4 %) characteristics than F1, F2, F3, F5 and F6 
(Figure 2 to 4) 
Based on our kinetic release study, we observed that 
TABLE II - Evaluation parameters for topical herbal gel formulation made with 1.5% Carbopol 934
Code Conc (%) pH* Viscosity* (poise)
Spreadability* 
g cm/sec
Net 
content* 
% w/w
Extrudability* Physical appearance
F1 0.5 7.57 0.3850 32.19 99.7 Good Greenish, smooth and 
translucent
F 2 1.0 7.57 0.3862 45.05 105 Excellent Dark green, smooth, 
homogenous, translucent
F 3 1.5 7.79 0.3873 56.39 105 Good Dark green, smooth, 
homogenous, translucent
F 4 2.0 7.60 0.3882 64.00 105 Excellent Dark green, smooth, 
homogenous, translucent
F 5 2.5 7.88 0.3891 71.38 101 Excellent Dark green, smooth, 
homogenous, translucent
F 6 3.0 7.42 0.3906 75.74 101 Excellent Dark green, smooth, 
homogenous, translucent
*Values mentioned are the average of five determinations
FIGURE 1 - In vitrodiffusion profile of topical herbal gels 
(F1-F6) and diclofenac sodium gel.
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of CHME and VNME prolonged its release of active 
constituents up to 5 h (almost 100%), making it suitable 
for sustained release and for better patient compliance. 
Thus from the release data observed using different 
mathematical models, gel formulation containing 2% of 
each of CHME and VNME showed zero order release 
kinetics (Table III). Since zero order kinetics follows 
controlled release, the gel formulation F4 containing 2% 
each of CHME and VNME was selected for in vivo studies 
Skin irritation test
The prepared herbal gel was evaluated for its skin 
irritant effect, where no erythema or edema was observed 
for all the formulations (Table IV), even after 10 days of 
study, indicating that the prepared herbal gel formulation 
was found to be safe.
Stability testing
In order to ensure the quality, safety and efficacy 
throughout the shelf life, stability study was performed 
as per ICH guidelines for F4 formulation (prepared using 
FIGURE 2 - Zero order plot for F4 topical herbal gel formulation.
FIGURE 3 - First order plot for F4 topical herbal gel formulation.
FIGURE 4 - Higuchi diffusion plot for F4 topical herbal gel 
formulation.
TABLE III - In vitro release kinetic study of topical herbal gel formulated with Carbopol 934
Formulation 
code
 Zero order 
R2
First Order 
R2
Higuchi diffusion model 
R2
Best fitted 
model
F1 0.969 0.911 >1 Zero order
F2 0.954 0.947 0.936 Zero order
F3 0.924 0.933 >1 First order
F4 0.989 0.913 >1 Zero order
F5 0.900 0.907 0.909 Higuchi
F6 0.912 0.892 0.917 Higuchi
the F4 formulation followed zero order kinetics. Since 
zero order kinetics is preferred for sustained release, gel 
formulation containing 2% each of CHME and VNME 
was selected for in vivo studies. Commercial diclofenac 
sodium gel formulation released almost 90% of its content 
within 3 h, whereas F4 formulation consisting of 2% each 
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carbopol 934) as it exhibited better quality characteristics. 
No change in color, odour, homogeneity, pH, viscosity 
and net content of the topical herbal gel formulation was 
observed for this formulation after 0,1,2,3 and 6 months 
of stability testing. Results of the study clearly revealed 
that the formulated topical gel F4 is found to be stable 
(Table V).
Body weight
The average gain/reduction in body weight was 
observed for all the groups after induction of arthritis in 
rats (Table VI). Reduction in body weight was observed 
for arthritic control group whereas gain in body weight 
was observed in diclofenac sodium gel and topical herbal 
TABLE IV- Primary skin irritation test for herbal gel formulation 940 and 934 
Rabbit Numbers Rabbit Combined 
index1 2 3 Control Average
1 h
Erythema Score 0 0 0 0 0.00 0.00
Edema Score 0 0 0 0 0.00
24 h
Erythema Score 0 0 0 0 0.00 0.00
Edema Score  0 0 0 0 0.00
48 h
Erythema Score 0 0 0 0 0.00 0.00
Edema Score 0 0 0 0 0.00
72 h
Erythema Score 0 0 0 0 0.00 0.00
Edema Score 0 0 0 0 0.00
7 days
Erythema Score 0 0 0 0 0.00 0.00
Edema Score 0 0 0 0 0.00
10 days
Erythema Score 0 0 0 0 0.00 0.00
Edema Score 0 0 0 0.00
TABLE V- Stability studies of topical herbal gel formulation
S.N Parameters
Topical herbal gel formulation (F4) containing 2% w/v of each CHME and VNME
St
ud
y
Ti
m
e p
er
io
d
Storage condition
25 °C ± 2 °C/60% RH ± 5% RH 32 °C ± 2 °C/60% RH ± 5% RH 40 °C ± 2 °C/75% RH ± 5% RH
Months Months Months
0 1 2 3 6 0 1 2 3 6 0 1 2 3 6
Sh
or
t t
er
m
Si
x 
M
on
th
s
1 Color No change in color No change in color No change in color
2 Odour No change in odour No change in odour No change in odour
3 Homogeneity Smooth Smooth Smooth
4 pH 6.44 6.42 6.39 6.37 6.34 6.43 6.40 6.41 6.38 6.36 6.42 6.40 6.37 6.35 6.34
5 Viscosity (poise) 0.385 0.385 0.380 0.375 0.370 0.385 0.383 0.380 0.376 0.372 0.385 0.380 0.378 0.370 0.364
6 Net content (%) 99 99 98 97 97 99 98 98 97 98 99 97 96 95 95
7 Microbial load (Bacteria & Fungi)
No microbial growth was observed at 
24, 48 and 72 h
No microbial growth was observed at 
24, 48 and 72 h
No microbial growth was observed at 
24, 48 and 72 h
8 Sterility test No microbial growth was observed at 24, 48 and 72 h
No microbial growth was observed at 
24, 48 and 72 h
No microbial growth was observed at 
24, 48 and 72 h
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gel formulation F4 treated groups, when compared with 
the normal group of rats.
Acute oral toxicity study
A detailed study on acute and sub-chronic toxicity of 
these plants was already reported by us revealed that the 
CH and VN extracts were nontoxic up to the dose of 2000 
mg/kg. (Rajasekaran, Arulkumaran, Arivukkarasu, 2015).
Paw volume
After topical application of diclofenac sodium gel 
and the herbal gel formulation (F4) from 22 to 42 days, 
changes in rat paw volume were recorded on 25th, 29th, 
35th and 42nd days (Table VII and Figure 5). The arthritic 
control groups showed signs of arthritis development as 
seen by increase in paw volume. Significant (p<0.01) 
reduction in rat paw volume was observed in diclofenac 
sodium gel treated groups and topical herbal gel 
formulation F4 treated groups, on 21st day after FCA 
induction.
The severity of arthritis was assessed by visual 
arthritic scoring systems described by Laird et al. (2001). 
The arthritic test scores were assigned as shown in Table 
VIII revealed that the pain associated with FCA induced 
arthritis was significantly decreased in diclofenac sodium 
gel treated and topical herbal gel formulation F4 treated 
groups. Significant alterations in flexion pain test score, 
mobility score and stance score was observed for all 
the treated group of rats when compared with arthritic 
control rats. This alteration of arthritic test scores 
support the anti-arthritic activity of the topical herbal 
gel formulation F4.
Among the formulations F1 to F6, F4 formulation 
was selected for anti-arthritic study as the results of quality 
control evaluation of formulation was found to be good 
and the in vitro release characteristics of the prepared 
topical gel formulations F4 was quite encouraging and in 
agreement with marketed diclofenac sodium gel.
TABLE VI - Effect of diclofenac sodium, F4 herbal gel formulation on body weight changes in FCA Induced arthritic rats
Groups Initial body weight (g) 
Body wt after 
21 days of FCA 
induction
Body wt after 
treatment 
25th day
Body wt after 
treatment 
29th day
Body wt after 
treatment 
35 th day
Body wt after 
treatment 
42nd day
Weight gain 
(g)
Normal Control 146.3 ± 0.84 172.2± 1.70 173.2 ± 1.89 177.50 ± 1.54 184.50 ± 1.12 192.70 ± 1.25 20.50±1.89
Arthritic control 145.3 ± 0.84 142.80 ± 0.79a  141.20 ± 0.94 a 138.30 ± 1.05 a 136.00 ± 1.13 a 132.70 ± 1.26 a -11.00±1.34
Diclofenac 
sodium topical 
gel (1% w/w)
145.00± 1.15 142.20 ± 1.25 a 143.00± 1.41 ns 144.20 ± 1.35 b 146.50 ± 1.83 a 149.80 ± 1.66 c 7.66±0.66
Topical herbal 
gel formulation 
(2% w/w)
145.5 ± 1.05 141.70 ± 1.38 a 142.20 ± 1.49 ns 143.00 ± 1.34 b 144.80 ± 1.56b 147.50 ± 1.71c 5.83±0.47
Data provided as mean ± SEM (n=6); ap<0.001 Arthritic control Vs Normal control; bp<0.05 Treated groups Vs Arthritic control; cp<0.001 Treated 
Groups Vs Arthritic control
TABLE VII - Evaluation of anti-arthritic activity of herbal gel formulation F4 in FCA induced arthritic rats
Groups
Rat paw volume (mm) 
Before treatment After treatment
Initial After 21 days 25th day 29thday 35th day 42nd day
Normal control 4.85± 0.14 5.16± 0.23 5.09 ± 0.20 5.39±0.10 5.63 ± 0.12 5.75 ± 0.78d
Arthritic control 4.81± 0.12 10.62± 0.15a 10.65 ± 0.26 a 10.68 ± 0.17 a 10.74 ± 0.23 a 10.79 ± 0.11 a
Diclofenac sodium topical gel (1 
% w/w)
5.10± 0.13 a 10.40± 0.15 a 10.47 ± 0.22ns 9.81 ± 0.16b 8.93 ± 0.23c 8.19 ± 0.07c
Topical herbal gel formulation 
F4 (2 % w/w)
4.95± 0.11a 10.38± 0.14 a 10.33 ± 0.14ns 9.74 ± 0.13c 9.15 ± 0.15c 8.73 ± 0.17c
Data provided as mean ± SEM (n=6). ap<0.001 Arthritic control Vs Normal control; bp<0.05 Treated groups Vs Arthritic control cp<0.001 Treated 
groups Vs Arthritic control. 
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FCA-induced arthritis is the most widely used 
model in which the clinical and pathological changes are 
comparable with those seen in human rheumatoid arthritis 
(Tsai, Lin, 1999).
FCA-induced polyarthritis is associated with an 
immune-mediated inflammatory reaction and the rat is 
unique in developing polyarthritis after FCA treatment 
(Nielen et al., 2006).
Selective reduction of arthritic score (Table VIII) 
and significant reduction in thymus and spleen weight 
in all the treated groups compared with arthritic rats 
supported the anti-arthritic activity.
Hematological parameters
Rats applied with diclofenac sodium gel and herbal 
gel formulation elicited decrease in WBC count, ESR 
and increase in Hb and RBC count, when compared with 
arthritic control groups (Table IX). 
Characteristic hematological alterations such as 
increased Hb and decrease in WBC count was observed 
after topical application of herbal gel and diclofenac 
sodium gel. It is proposed that the reduction in the Hb count 
during arthritis results from reduced erythropoietin levels, 
a decreased response of the bone marrow erythropoietin 
and premature destruction of red blood cells. It has been 
reported that a moderate rise in the WBC count occurs in 
arthritic conditions due to an IL-1B mediated rise in the 
respective colony stimulating factors. The present study 
reveals that topical herbal gel and diclofenac sodium gel 
treatments tend to normalize the WBC count. 
Biochemical parameters
Significant (p<0.01)decrease in urea and uric acid 
FIGURE 5 - Herbal gel formulation F4 in FCA induced arthritic 
rats.
TABLE VIII - Alterations in various pain test scores in FCA Induced arthritis in rats
Groups
Pain test
Mobility score Stance score
Extension Flexion
Arthritic control 9.5 ± 0.34 8.33 ± 0.33 1.33 ± 0.21 1.50 ± 0.22
diclofenac sodium 
topical gel (1 % w/w)
5.16 ± 0.16d 4.66 ± 0.21 d 2.66 ± 0.21d 2.33 ± 0.21d
Topical herbal gel 
formulation (2% w/w)
4.66 ± 0.21d 3.66 ± 0.33 d 3.16 ± 0.21d 2.83 ± 0.16d
Data provided as mean ± SEM (n=6); dp<0.001 Treated groups Vs Arthritic control
TABLE IX - Effect of formulation F4 on hematological parameters in FCA induced arthritic rats
Groups 
Hb (mg%) WBC (x103/mm3) RBC (x106/mm3) ESR (mm/h)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Normal control 15.92±0.18 16.38±0.15 6.53±0.15 6.85±0.12 9.64±0.06 10.22±0.20 5.50±0.42 5.16±0.40
Arthritic control 11.02 ± 0.30a 9.98±0.17a 11.97±0.22a 10.88±0.15a 7.99±0.20 6.31±0.14a 34.67±1.22a 42.83±1.35a
Diclofenac sodium topical gel 1% w/w 11.23±0.21a 14.97±0.26b 11.28±0.19 a 8.10±0.09b 7.36±0.25 a 8.86±0.21b 38.17±0.83a 27.17±2.02b
Topical herbal gel formulation 2% w/w 12.22± 0.14a 13.48±0.18b 11.93±0.40a 9.41 ±0.04b 7.18 ±0.23a 8.16 ±0.10b 40.67± 0.55a 31.33±1.83b
Data provided as mean ± SEM (n=6); ap<0.001 Arthritic control Vs Normal control; bp<0.001 Treated groups Vs Arthritic control
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concentration was observed in diclofenac sodium gel and 
herbal gel formulation F4 treated groups, when compared 
with the arthritic control group (Table X).
Serum biomarkers
In vitro determination of CRP
The serum of the tested animal groups before 
treatment showed agglutination and no agglutination was 
observed for the serum of groups treated with diclofenac 
sodium topical gel and topical herbal gel F4 formulation.
In vitro determination of rheumatic factor
Auto antibodies termed as “Rheumatoid Factor 
is the most useful prognostic marker for the diagnosis 
of rheumatoid arthritis, agglutination is used because 
greater sensitivity and simplicity. No agglutination was 
observed in the serum of the tested animal groups treated 
with diclofenac sodium topical gel and topical herbal gel 
F4 formulation.
In vitro determination of TNF-α
TNFα level in arthritic induced rats was found to be 
44.90 pg/mL. The TNFα level of diclofenac sodium topical 
gel treated and topical herbal gel formulation F4 treated 
group was found to be less than the arthritic induced rats. 
Thus this study revealed that diclofenac sodium topical 
gel and topical herbal gel formulation F4 treated groups 
reduced the levels of TNFα (Table XI).
In vitro determination of IL-1b and IL-6
The cytokine levels was found to be increased in 
arthritic control, which was significantly (p<0.01) reduced 
in diclofenac sodium gel treated groups and herbal gel 
formulation treated groups (Table XII).
Spleen and thymus weight
The weights of spleen and thymus recorded after 
sacrificing the rats on 42nd day. Significant (p<0.01) 
reduction of spleen and thymus weight was observed 
for diclofenac sodium gel treated groups and herbal gel 
TABLE X -Effect of formulation F4 on biochemical parameters in FCA induced arthritic rats
Group
Urea (mg/dL) Uric acid (mg /dL)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Before 
treatment 
(21st day)
After 
treatment 
(42nd day)
Normal control 16.05 ± 0.60 16.42±0.59 2.85±0.05 2.91±0.07
Arthritic control 44.70±0.92a 46.57±0.94a 7.16±0.15a 7.40±0.18a
Diclofenac sodium topical gel (1% w/w) 45.33 ± 0.7 a 28.17 ±1.17b 6.63 ±0.58 a 5.16±0.24b
Topical herbal gel formulation (2% w/w ) 44.17±0.70a 34.97±0.76b 7.15±0.14 a 5.45±0.31b
Data provided as mean ± SEM (n=6); ap<0.001 Arthritic control vs Normal control; bp<0.001 Treated groups Vs Arthritic control
TABLE XI - In vitro determination of serum TNFα level in FCA 
induced arthritic rats
Groups TNFα (pg/mL)
Normal control 1.36 ± 0.23
Arthritic control 44.90 ± 2.36a
Diclofenac sodium topical gel 1% w/w 6.28 ± 0.71b
Topical herbal gel formulation 2% w/w 19.79 ± 0.81b
All the values are mean ± SEM (n=6). ap<0.01 arthritic control 
Vs normal control; bp<0.01, treatment groups Vs arthritic control
TABLE XII - In vitro determination of serum Interleukin levels (IL-1ß and IL-6) in FCA induced arthritic rats
Groups 
Serum interleukin (pg/mL)
IL-1β IL-6
 Normal control 1.38 ± 0.24 19.58 ± 1.14
Arthritic control 67.70 ± 1.09a 728.61 ± 31.99a
Diclofenac sodium topical gel (1% w/w) 20.99 ± 0.60b 313.95±14.66 b
Topical herbal gel formulation (2% w/w) 36.55 ± 1.25b 428.12 ± 10.17b
Data provided as mean ± SEM (n=6); ap<0.01, Arthritic control Vs Normal control; bp<0.01, Treatment groups Vs Arthritic control
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formulation F4 treated groups when compared with the 
arthritic control group (Table XIII).
Increase in serum levels of CRP, RF TNF-α, IL1β 
and IL6 are characteristic features of RA (Feldmann, 
Manini, 2008) and hence, in vitro determination of serum 
biomarkers such as CRP, RF, TNF-α, IL1β and IL6 were 
performed for the arthritic control and all the treated 
groups. Significant inhibition of IL-1ß, TNF-α and IL-6 
production, suggests that topical herbal gel formulation 
may have the potential to regulate pro-inflammatory 
cytokines which is in correlation with the reported 
literature (Choi, Lee, 2010).
Histopathological examination
Histological examination of normal specimen of 
joint showed normal joint space, normal adjacent soft 
tissue, synovium and cartilage (Figure 6A, 6B). Arthritis 
control specimen of joint showed with dense inflammation 
in the soft tissue around the joint. Specimen of joint of 
diclofenac sodium topical gel treated groups showed 
normal cartilage, cortex and marrow (Figure 6C, 6D). 
Histopathological examination of topical diclofenac 
sodium gel and topical herbal gel formulation F4 treated 
arthritic rats showed reduction in inflammation in the 
soft tissue around the joint when compared with arthritic 
control rats (Figure 6G, 6H).
CONCLUSION
Anti-arthritic activity of the developed topical herbal 
gel formulation may be due to the presence of luteolin 
and apigenin in methanol leaf extracts of Cardiospermum 
halicacabum and Vitex negundo (Sharififar, Dehghn-
Nudeh, Mirtajaldini, 2009). The developed formulation 
F4 consisting 2% each of CHME and VNME with 1.5% 
of carbopol 934 was found to be promising topical herbal 
gel for the treatment of arthritis. Further clinical studies 
can strengthen the use of this formulation for the patients 
suffering from joint inflammatory disorders. 
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TABLE XIII - Effect of F4 formulation on thymus and spleen weight changes in FCA induced arthritic rats
Group Thymus weight (g) Spleen weight (g)
Normal control 0.15 ± 0.010 0.58 ± 0.011
Arthritic control 0.65 ± 0.009a 1.33 ± 0.064a
Diclofenac sodium topical gel (1% w/w) 0.37 ± 0.009b 0.74 ± 0.011b
Topical herbal gel formulation (2 % w/w) 0.43 ± 0.007b 0.89 ± 0.015b
Data provided as mean ± SEM (n=6); ap<0.001 Arthritic control Vs Normal control; bp<0.0001 Treatment groups Vs Arthritic control
FIGURE 6A - Histopathological section of ankle joint of control 
group of rat under 10 X showing normal joint surface.
FIGURE 6C- Histopathological section of ankle joint of arthritic 
control group of rat under 10 X showing inflammation.
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FIGURE 6B- Histopathological section of ankle joint of control 
group of rat under . 40 X showing normal cartilage and cortex. 
FIGURE 6D - Histopathological section of ankle joint of arthritic 
control group of rat under 40 X showing inflammation.
FIGURE 6F- Histopathological section of ankle joint of 
diclofenac gel treated group of rat under 40 X showing normal 
cartilage and cortex and marrow.
FIGURE 6E- Histopathological section of ankle joint of 
diclofenac gel treated group of rat under 10 X showing normal 
cartilage and cortex and marrow.
FIGURE 6G - Histopathological section of ankle joint of herbal 
gel treated group Of rat under 10 X showing mild inflammation.
FIGURE 6H - Histopathological section of ankle joint of herbal 
gel treated group of rat under 40 X showing mild .inflammation.
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